ACHV - Achieve Life Sciences Inc.
IEX Last Trade
4.39
-0.040 -0.911%
Share volume: 159,224
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.43
-0.04
-0.90%
Fundamental analysis
8%
Profitability
8%
Dept financing
4%
Liquidity
50%
Performance
0%
Performance
5 Days
-2.66%
1 Month
-10.95%
3 Months
-17.17%
6 Months
-1.57%
1 Year
-10.04%
2 Year
-2.66%
Key data
Stock price
$4.39
DAY RANGE
$4.23 - N/A
52 WEEK RANGE
$3.03 - $5.98
52 WEEK CHANGE
-$0.15
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Richard Stewart
Region: US
Website: http://achievelifesciences.com/
Employees: 15
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://achievelifesciences.com/
Employees: 15
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.
Recent news